PROBLEM: We previously reported a diminished expression of the heme-degrading enzymes heme oxygenases (HO)-1 and HO-2 in decidua and placenta from mice undergoing Th1-mediated abortion, strongly indicating the protective effect of HO in murine pregnancy maintenance. Here we investigated whether the expression of HO-1 and HO-2 is also reduced at the feto-maternal interface of pathologic human pregnancies. METHOD OF STUDY: Immunohistochemistry was used to detect HOs expression in placental and decidual first-trimester tissue from patients with: spontaneous abortion (n = 14), choriocarcinoma (n = 14), hydatidiform mole (H-mole) (n = 12), compared with normally progressing pregnancies (n = 15). Further, we investigated early third-trimester decidual and placental tissue from patients with pre-eclampsia (n = 13) compared with fetal growth retardation (n = 14) as age-matched controls. RESULTS: In first trimester tissue, we observed a significant reduction of HO-2 expression in invasive trophoblast cells, endothelial cells, and syncytiotrophoblasts in samples from patients with spontaneous abortion compared with normal pregnancy. H-mole samples showed a diminished expression of HO-2 in invasive trophoblast cells and endothelial cells in comparison with NP, whereas choriocarcinoma samples showed no significant differences compared with the control. In third trimester tissue, HO-2 was also reduced in syncytiotrophoblasts and invasive trophoblast cells from pre-eclampsia compared with samples from fetal growth retardation. HO-1 expression was diminished in all pathologies investigated; however, the differences did not reach levels of significance. CONCLUSIONS: Our data indicate that HOs play a crucial role in pregnancy and low expression of HO-2, as observed in pathologic pregnancies, may lead to enhanced levels of free heme at the feto-maternal interface, with subsequent upregulation of adhesion molecules, allowing enhanced inflammatory cells migration to the feto-maternal interface.
PROBLEM: We previously reported a diminished expression of the heme-degrading enzymes heme oxygenases (HO)-1 and HO-2 in decidua and placenta from mice undergoing Th1-mediated abortion, strongly indicating the protective effect of HO in murine pregnancy maintenance. Here we investigated whether the expression of HO-1 and HO-2 is also reduced at the feto-maternal interface of pathologic human pregnancies. METHOD OF STUDY: Immunohistochemistry was used to detect HOs expression in placental and decidual first-trimester tissue from patients with: spontaneous abortion (n = 14), choriocarcinoma (n = 14), hydatidiform mole (H-mole) (n = 12), compared with normally progressing pregnancies (n = 15). Further, we investigated early third-trimester decidual and placental tissue from patients with pre-eclampsia (n = 13) compared with fetal growth retardation (n = 14) as age-matched controls. RESULTS: In first trimester tissue, we observed a significant reduction of HO-2 expression in invasive trophoblast cells, endothelial cells, and syncytiotrophoblasts in samples from patients with spontaneous abortion compared with normal pregnancy. H-mole samples showed a diminished expression of HO-2 in invasive trophoblast cells and endothelial cells in comparison with NP, whereas choriocarcinoma samples showed no significant differences compared with the control. In third trimester tissue, HO-2 was also reduced in syncytiotrophoblasts and invasive trophoblast cells from pre-eclampsia compared with samples from fetal growth retardation. HO-1 expression was diminished in all pathologies investigated; however, the differences did not reach levels of significance. CONCLUSIONS: Our data indicate that HOs play a crucial role in pregnancy and low expression of HO-2, as observed in pathologic pregnancies, may lead to enhanced levels of free heme at the feto-maternal interface, with subsequent upregulation of adhesion molecules, allowing enhanced inflammatory cells migration to the feto-maternal interface.
Authors: Eric M George; Junie P Warrington; Frank T Spradley; Ana C Palei; Joey P Granger Journal: Am J Physiol Regul Integr Comp Physiol Date: 2014-06-04 Impact factor: 3.619
Authors: Lars Bellner; Jesse Wolstein; Kiran A Patil; Michael W Dunn; Michal Laniado-Schwartzman Journal: Invest Ophthalmol Vis Sci Date: 2011-05-17 Impact factor: 4.799
Authors: Adna Halilovic; Kiran A Patil; Lars Bellner; Giuseppina Marrazzo; Kirkland Castellano; Giuseppe Cullaro; Michael W Dunn; Michal Laniado Schwartzman Journal: J Cell Physiol Date: 2011-07 Impact factor: 6.384
Authors: Junie P Warrington; Kayla Coleman; Courtney Skaggs; Peter A Hosick; Eric M George; David E Stec; Michael J Ryan; Joey P Granger; Heather A Drummond Journal: Am J Physiol Regul Integr Comp Physiol Date: 2014-02-19 Impact factor: 3.619
Authors: Francesca Seta; Lars Bellner; Rita Rezzani; Raymond F Regan; Michael W Dunn; Nader G Abraham; Karsten Gronert; Michal Laniado-Schwartzman Journal: Am J Pathol Date: 2006-11 Impact factor: 4.307
Authors: Satyan S Kalkunte; Stefan Neubeck; Wendy E Norris; Shi-Bin Cheng; Stefan Kostadinov; Dang Vu Hoang; Aftab Ahmed; Ferdinand von Eggeling; Zahir Shaikh; James Padbury; Goran Berg; Anders Olofsson; Udo R Markert; Surendra Sharma Journal: Am J Pathol Date: 2013-09-10 Impact factor: 4.307